semaglutide alzheimer's disease clinical trial evoke and evoke+: design of two large-scale, double-blind, placebo- controlled, phase 3 studies evaluating efficacy, safety, and tolerability of in early-stage symptomatic | Alzheimer's Research & Therapy GLP-1 Drug Fails to Improve
Pay in 4 interest-free payments of $7.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28











:max_bytes(150000):strip_icc()/Health-GettyImages-1675158771-70640c9fdf1b41078975cfc3fd538a6b.jpg)








![Supelco [(3R)-3-Hydroxybutyryl]-ʟ-carnitine, CAS 918639-76-6, analytical standard 10 mg](https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/structures/658/500/ff9570f8-a346-4077-9983-d0e67400bf47/640/ff9570f8-a346-4077-9983-d0e67400bf47.png)





